Morewood and ItxM link up on blood-clotting test:
This article was originally published in Clinica
Executive Summary
Morewood Molecular Sciences has entered into a research and development project with the Institute for Transfusion Medicine (ITxM) to develop and validate a microarray system that Morewood claims could improve current blood-clotting tests by "multiple orders of magnitude". The new chip will simultaneously assay hundreds of enzyme reactions using only microlitre quantities of a blood sample, in contrast to the large quantities of blood required to perform a number of similar tests today, says the Pittsburgh, Pennsylvania firm.